1.
Bioorg Med Chem Lett
; 17(23): 6525-8, 2007 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17936624
RESUMO
We describe three novel regioisomeric series of aryl naphthyridine analogs, which are potent antagonists of the Class III GPCR mGlu5 receptor. The synthesis and in vitro and in vivo pharmacological activities of these analogs are discussed.